TidePoint Consulting partners with biopharmaceutical and life sciences organizations — pairing field medical expertise with strategic, board-level counsel that moves programs and companies forward.
From the clinic to the boardroom, we help life sciences teams make confident decisions at the moments that matter most.
Building and sharpening the medical affairs engine that connects your science to the clinical community.
Independent, board-level counsel for clinical-stage and commercial biopharma navigating growth and inflection.
Translating clinical and scientific insight into commercial direction across therapeutic areas.
A tide point is where the current turns — the moment that decides what comes next. It's where we do our best work.
We stay deliberately small and senior. Every engagement is led directly by principals with deep operating and scientific experience, not handed down a chain. The result is candid advice, full discretion, and judgment earned across the life sciences landscape.
TidePoint Consulting is a California advisory firm working at the intersection of medical strategy and corporate direction in biopharma. We bring the rigor of the clinic together with the perspective of the boardroom — helping leadership teams see clearly and act decisively.
A biopharmaceutical executive with more than 30 years turning science into commercial reality, Craig is CEO of Cerevance and a board director at Esperion Therapeutics and NervGen Pharma. His career spans leadership roles at Neurana, Anthera, Tetraphase, and Trius Therapeutics — where he co-led the M&A behind Cubist's $818M acquisition — built on global brand leadership at Merck and Pfizer. He founded TidePoint to bring that commercial and operating perspective to life sciences leaders.
A Medical Science Liaison and Medical Affairs leader with deep expertise across neuroscience, oncology diagnostics and screening (MCED, CRC, HCC), and infectious diseases, Gina serves as Medical Affairs Lead and Clinical Trial Lead at Cerevance, supporting global Phase II and III programs. A published researcher and Board Certified Medical Affairs Specialist, she holds a PharmD and an MPH in epidemiology, with two decades building national and international KOL relationships and leading MSL teams.
A University of Toronto graduate with a double major in Neuroscience and Physiology and a varsity rowing athlete, Emily supports the firm's clinical research and medical writing — translating complex science into clear, evidence-based work.
An emergency medicine nurse, Kaitlyn brings frontline clinical perspective to the firm, with expertise across emergency care, clinical documentation, and patient experience.
A Georgetown University student studying Finance and Operations & Analytics, Sarah supports the firm's finance and operations work as an intern.